This Article Full Text Full Text (PDF) All Versions of this Article: 18/9/2268    most recent Author Manuscript (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Grey, A. Articles by Cornish, J. Search for Related Content PubMed PubMed Citation Articles by Grey, A. Articles by Cornish, J.

The Low-Density Lipoprotein Receptor-Related Protein 1 Is a Mitogenic Receptor for Lactoferrin in Osteoblastic Cells

Department of Medicine (A.G., T.B., Q.Z., M.W., K.C., D.N., I.R.R., J.C.), and Department of Anatomy (J.R.), University of Auckland, Private Bag 92019, Auckland, New Zealand; and Fonterra Research Center (K.P.), Palmerston North 5315, New Zealand

Address all correspondence and requests for reprints to: Dr. Andrew Grey, Department of Medicine, University of Auckland, Private Bag 92019, Auckland, New Zealand. E-mail: a.grey{at}auckland.ac.nz.

Lactoferrin induces osteoblast proliferation and survival in vitro and is anabolic to bone in vivo. The molecular mechanisms by which lactoferrin exerts these biological actions are not known, but lactoferrin is known to bind to two members of the low-density lipoprotein receptor family, low- density lipoprotein receptor-related proteins 1 (LRP1) and 2 (LRP2). We have examined the role(s) of these receptors in the actions of lactoferrin on osteoblasts. We show that lactoferrin binds to cultured osteoblastic cells, and that LRP1 and LRP2 are expressed in several osteoblastic cell types. In primary rat osteoblastic cells, the LRP1/2 inhibitor receptor associated protein blocks endocytosis of lactoferrin and abrogates lactoferrin-induced p42/44 MAPK signaling and mitogenesis. Lactoferrin-induced mitogenesis is also inhibited by an antibody to LRP1. Lactoferrin also induces receptor associated protein-sensitive activation of p42/44 MAPK signaling and proliferation in osteoblastic human SaOS-2 cells, which express LRP1 but not LRP2. The mitogenic response of LRP1-null fibroblastic cells to lactoferrin is substantially reduced compared with that of cells expressing wild-type LRP1. The endocytic and signaling functions of LRP1 are independent of each other, because lactoferrin can activate mitogenic signaling in conditions in which endocytosis is inhibited. Taken together, these results 1) suggest that mitogenic signaling through LRP1 to p42/44 MAPKs contributes to the anabolic skeletal actions of lactoferrin; 2) demonstrate growth-promoting actions of a third LRP family member in osteoblasts; and 3) provide further evidence that LRP1 functions as a signaling receptor in addition to its recognized role in ligand endocytosis.

This article has been cited by other articles:

				M. Spadaro, C. Caorsi, P. Ceruti, A. Varadhachary, G. Forni, F. Pericle, and M. Giovarelli Lactoferrin, a major defense protein of innate immunity, is a novel maturation factor for human dendritic cells FASEB J, August 1, 2008; 22(8): 2747 - 2757. [Abstract] [Full Text] [PDF]

				A. P. Lillis, L. B. Van Duyn, J. E. Murphy-Ullrich, and D. K. Strickland LDL Receptor-Related Protein 1: Unique Tissue-Specific Functions Revealed by Selective Gene Knockout Studies Physiol Rev, July 1, 2008; 88(3): 887 - 918. [Abstract] [Full Text] [PDF]

				V. Saraswathi and A. H. Hasty The role of lipolysis in mediating the proinflammatory effects of very low density lipoproteins in mouse peritoneal macrophages J. Lipid Res., July 1, 2006; 47(7): 1406 - 1415. [Abstract] [Full Text] [PDF]

				D. Naot, A. Grey, I. R Reid, and J. Cornish Lactoferrin - A Novel Bone Growth Factor Clin. Med. Res., May 1, 2005; 3(2): 93 - 101. [Abstract] [Full Text] [PDF]